1.
High Uptake of Respiratory Syncitial Virus Prevention for Neonates in a Military Treatment Facility.
J Pediatr
; : 114144, 2024 Jun 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38876155
RESUMO
We investigated the uptake of nirsevimab for infants and RSVPreF vaccine for pregnant persons as measures for respiratory syncytial virus (RSV) prevention during an infant's birth hospitalization in a military treatment facility. We found >85% uptake between October 2023 to February 2024. These data may aid health systems plan for future RSV seasons.